Patent Expiry
ASND: Patent_Expiry: NDA219164
February 27, 2033 · NAVEPEGRITIDE. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- February 27, 2033
- Company
- Ascendis Pharma A/S (ASND)
- Drug
- NAVEPEGRITIDE
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
Patent_Expiry: NDA219164
Orange Book application NDA219164, product 001; overall loss of exclusivity is unverified. Overall loss of exclusivity and current company rights: unknown.FDA source
- Company
- Ascendis Pharma A/S (ASND)
- Drug
- NAVEPEGRITIDE